Supplementary Figure 1 from Extended 5-Year Follow-up Results of a Phase Ib Study (BRIM7) of Vemurafenib and Cobimetinib in BRAF-Mutant MelanomaAntoni Ribas,Adil Daud,Anna C. Pavlick,Rene Gonzalez,Karl D. Lewis,Omid Hamid,Thomas F. Gajewski,Igor Puzanov,Matthew Wongchenko,Isabelle Rooney,Jessie J. Hsu,Yibing Yan,Erica Park,Grant A. McArthuropenalex（2023）引用 0|浏览2关键词MelanomaAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
